Momelotinib vs. ruxolitinib in myelofibrosis patient subgroups by baseline hemoglobin levels in the SIMPLIFY-1 trial

2024
journal article
article
6
dc.cm.id115254pl
dc.cm.idOmegaUJCM1122656adb9e4f19b64550472a75bf47pl
dc.contributor.authorGupta, Vikaspl
dc.contributor.authorOh, Stephenpl
dc.contributor.authorDevos, Timothypl
dc.contributor.authorDubruille, Vivianepl
dc.contributor.authorCatalano, Johnpl
dc.contributor.authorSomervaille, Tim C.P.pl
dc.contributor.authorPlatzbecker, Uwepl
dc.contributor.authorGiraldo, Pilarpl
dc.contributor.authorKosugi, Hiroshipl
dc.contributor.authorSacha, Tomasz - 133344 pl
dc.contributor.authorMayer, Jiripl
dc.contributor.authorIlles, Arpadpl
dc.contributor.authorEllis, Catherinepl
dc.contributor.authorWang, Zhaohuipl
dc.contributor.authorGonzalez Carreras , Francisco J.pl
dc.contributor.authorStrouse, Bryanpl
dc.contributor.authorMesa, Rubenpl
dc.date.accession2024-06-10pl
dc.date.accessioned2024-06-10T22:32:13Z
dc.date.available2024-06-10T22:32:13Z
dc.date.issued2024pl
dc.description.physical1-13pl
dc.description.volume63pl
dc.identifier.doi10.1080/10428194.2024.2328800pl
dc.identifier.eissn1029-2403pl
dc.identifier.issn1042-8194pl
dc.identifier.urihttps://ruj.uj.edu.pl/handle/item/346215
dc.languageengpl
dc.language.containerengpl
dc.rightsDodaję tylko opis bibliograficzny*
dc.rights.licenceBez licencji otwartego dostępupl
dc.rights.uri*
dc.subtypeArticlepl
dc.titleMomelotinib vs. ruxolitinib in myelofibrosis patient subgroups by baseline hemoglobin levels in the SIMPLIFY-1 trialpl
dc.title.journalLeukemia and Lymphomapl
dc.typeJournalArticlepl
dspace.entity.typePublication
dc.cm.idpl
115254
dc.cm.idOmegapl
UJCM1122656adb9e4f19b64550472a75bf47
dc.contributor.authorpl
Gupta, Vikas
dc.contributor.authorpl
Oh, Stephen
dc.contributor.authorpl
Devos, Timothy
dc.contributor.authorpl
Dubruille, Viviane
dc.contributor.authorpl
Catalano, John
dc.contributor.authorpl
Somervaille, Tim C.P.
dc.contributor.authorpl
Platzbecker, Uwe
dc.contributor.authorpl
Giraldo, Pilar
dc.contributor.authorpl
Kosugi, Hiroshi
dc.contributor.authorpl
Sacha, Tomasz - 133344
dc.contributor.authorpl
Mayer, Jiri
dc.contributor.authorpl
Illes, Arpad
dc.contributor.authorpl
Ellis, Catherine
dc.contributor.authorpl
Wang, Zhaohui
dc.contributor.authorpl
Gonzalez Carreras , Francisco J.
dc.contributor.authorpl
Strouse, Bryan
dc.contributor.authorpl
Mesa, Ruben
dc.date.accessionpl
2024-06-10
dc.date.accessioned
2024-06-10T22:32:13Z
dc.date.available
2024-06-10T22:32:13Z
dc.date.issuedpl
2024
dc.description.physicalpl
1-13
dc.description.volumepl
63
dc.identifier.doipl
10.1080/10428194.2024.2328800
dc.identifier.eissnpl
1029-2403
dc.identifier.issnpl
1042-8194
dc.identifier.uri
https://ruj.uj.edu.pl/handle/item/346215
dc.languagepl
eng
dc.language.containerpl
eng
dc.rights*
Dodaję tylko opis bibliograficzny
dc.rights.licencepl
Bez licencji otwartego dostępu
dc.rights.uri*
dc.subtypepl
Article
dc.titlepl
Momelotinib vs. ruxolitinib in myelofibrosis patient subgroups by baseline hemoglobin levels in the SIMPLIFY-1 trial
dc.title.journalpl
Leukemia and Lymphoma
dc.typepl
JournalArticle
dspace.entity.type
Publication
Affiliations

* The migration of download and view statistics prior to the date of April 8, 2024 is in progress.

Views
4
Views per month
Views per city
Krakow
1
Milan
1
Tokyo
1

No access

No Thumbnail Available